MNPR - Monopar Therapeutics
57.61
1.810 3.142%
Share volume: 169,583
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$55.80
1.81
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-08-2024 | 05-13-2025 | 11-13-2025 | |
| Cash flow financing | 3.182 M | -9.919 K | -16.534 K | -115.682 K | 92.392 M | |
| Other financing cash flows | -10.738 K | -9.918 K | -16.534 K | -115.682 K | -381.349 K | |
| Cash flow | 543.151 K | -1.689 M | -104.304 K | -6.105 M | 88.175 M | |
| Net income | -1.641 M | -1.715 M | -1.304 M | -2.625 M | -3.438 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -983.307 K | -2.423 K | 985.730 K | -325.828 K | -2.126 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 541.499 K | -1.688 M | -99.847 K | -6.105 M | 88.175 M |